CDKN2B

OMIMHGNC

Synonym(s): P15, MTS2, INK4B, TP15, CDK4I, p15INK4b

Locus: 9p21.3

Protein: Cyclin-dependent kinase inhibitor 2B

Tests

Test Type
Molecular (6)
Multi-Gene Panel (3)
Multi-Method Panel (4)
Test Method
Del/Dup (CNV) (4)
Methylation Analysis (1)
Sequencing, Capillary (Sanger) (3)
Sequencing, Next Gen (4)
Prenatal/Carrier
Carrier (2)
Lab Location
Portugal(1)
USA(2)
Germany(2)
Spain(1)
 
TAT: 4-6 weeks
price: contact lab
Somatic Tumor Panel
method(s): ◦ Sequencing, Next Gen 
CeGaT GmbH - Tübingen, Germany
TAT: 4 weeks
price: contact lab
Melanoma (methylation and deletion/duplication analysis of CDKN2A and CDKN2B genes, sample of tumoral tissue)
method(s): ◦ Del/Dup (CNV) ◦ Methylation Analysis 
CGC Genetics - Porto, Portugal
Cutaneous Malignant Melanoma, Panel Massive Sequencing (NGS) 11 Genes
method(s): ◦ Sequencing, Next Gen 
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain
TAT: 4-5 Weeks
price: contact lab
CDKN2B
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Fulgent Diagnostics - Temple City, CA, USA
TAT: 4-5 Weeks
price: contact lab
CDKN2B-AS1
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Fulgent Diagnostics - Temple City, CA, USA
TAT: 3-4 weeks
price: contact lab
Multiple endocrine neoplasia type 1, CDKN2B related
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Centogene AG, Rare Disease Company - Rostock, Germany